Document is current

Article History

Received: 15 May 2020

Accepted: 1 July 2020

First Online: 31 July 2020

Ethics approval and consent to participate

: Not applicable

: Not applicable

: Dr. Pascual received research grants (Camurus) and lectures/training programs (Lundbeck, Gilead, Abbvie, Neuraxpharm, Pfizer).Dr. Aubin reported being a member of advisory boards or DSMB for Bioprojet, CV Sciences, and Ethypharm, and has received sponsorship to attend scientific meetings, speaker honoraria, or consultancy fees from Bioprojet, D&A Pharma, Ethypharm, Kinnov Pharmaceuticals, and Lundbeck. He is also a member of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative (ACTIVE), which was supported in the last 3 years by Alkermes, Amygdala Neurosciences, Arbor Pharmaceuticals, Ethypharm, Indivior, Lundbeck, Mitsubishi, and Otsuka.Dr. Gual received a grant from Novartis for a trial on cocaine that ended in April 2020.Dr. López-Pelayo received training grants (Exeltis, Lundbeck).Dr. Saitz declares that Alkermes provides medication to Boston University for a trial supported by the US National Institutes of Health for which Dr. Saitz is the principal investigator. Dr. Saitz consults for various non-profit institutions and universities as a lecturer, expert, researcher, and editor in the area of addiction. He is the Editor-in-Chief of <i>Journal of Addiction Medicine</i> and the President of International Society of Addiction Journal Editors. He is an investigator for studies supported by the National Institutes of Health and faculty for a training program supported by the Burroughs Wellcome Foundation.Dr. Dom is a member of the scientific advisory board of Janssen-Cilag NV, Belgium.None of the previous conflicts of interest has relationship with this work.Others authors do not report any conflict of interest.